Imunon Inc
IMNN9.151USD
+0.651+7.66%
시장 운영 시간 （ET）시세는 15분 지연됩니다
133.79M시가총액
손실P/E TTM
자세한 내용은 Imunon Inc 회사
Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases. The Company is developing non-viral Deoxyribonucleic acid (DNA) technology across four modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit a strong immunological response. The third modality, FixPlas, concerns the application of Imunon’s DNA technology to produce universal cancer vaccines, also called tumor associated antigen cancer vaccines. The fourth modality, IndiPlas, is in the discovery phase and is focused on the development of personalized cancer vaccines, or neoepitope cancer vaccines. Its lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer.
회사 정보
종목 코드 IMNN
회사 이름Imunon Inc
상장일Oct 27, 1993
CEODr. Stacy R. Lindborg, Ph.D.
직원 수25
유형Ordinary Share
회계 연도 종료Oct 27
주소997 Lenox Dr Ste 100
도시LAWRENCEVILLE
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호08648
전화16098969100
웹사이트https://imunon.com/
종목 코드 IMNN
상장일Oct 27, 1993
CEODr. Stacy R. Lindborg, Ph.D.
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Michael H. Tardugno
Mr. Michael H. Tardugno
Executive Chairman of the Board
Executive Chairman of the Board
4.91K
+6.62%
Dr. Khursheed Anwer, Ph.D.
Dr. Khursheed Anwer, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
2.97K
+246.67%
Dr. Donald P. Braun, Ph.D.
Dr. Donald P. Braun, Ph.D.
Independent Director
Independent Director
1.71K
--
Mr. Frederick J. (Fred) Fritz
Mr. Frederick J. (Fred) Fritz
Independent Director
Independent Director
784.00
--
Ms. Kimberly Graper
Ms. Kimberly Graper
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan Eylward
Ms. Susan Eylward
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Dr. Stacy R. Lindborg, Ph.D.
Dr. Stacy R. Lindborg, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Dr. Douglas Vincent Faller, M.D., Ph.D.
Dr. Douglas Vincent Faller, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Independent Director
Independent Director
--
--
Mr. James E. Dentzer
Mr. James E. Dentzer
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Michael H. Tardugno
Mr. Michael H. Tardugno
Executive Chairman of the Board
Executive Chairman of the Board
4.91K
+6.62%
Dr. Khursheed Anwer, Ph.D.
Dr. Khursheed Anwer, Ph.D.
Executive Vice President, Chief Scientific Officer
Executive Vice President, Chief Scientific Officer
2.97K
+246.67%
Dr. Donald P. Braun, Ph.D.
Dr. Donald P. Braun, Ph.D.
Independent Director
Independent Director
1.71K
--
Mr. Frederick J. (Fred) Fritz
Mr. Frederick J. (Fred) Fritz
Independent Director
Independent Director
784.00
--
Ms. Kimberly Graper
Ms. Kimberly Graper
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Ms. Susan Eylward
Ms. Susan Eylward
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Sat, Jul 26
마지막 업데이트: Sat, Jul 26
주주
주주 유형
주주
주주
비율
Intracoastal Capital, L.L.C.
3.49%
Geode Capital Management, L.L.C.
0.45%
Tardugno (Michael H)
0.23%
BlackRock Institutional Trust Company, N.A.
0.18%
Le (Goff Corinne)
0.17%
Other
95.48%
주주
주주
비율
Intracoastal Capital, L.L.C.
3.49%
Geode Capital Management, L.L.C.
0.45%
Tardugno (Michael H)
0.23%
BlackRock Institutional Trust Company, N.A.
0.18%
Le (Goff Corinne)
0.17%
Other
95.48%
주주 유형
주주
비율
Corporation
3.49%
Individual Investor
0.76%
Investment Advisor/Hedge Fund
0.69%
Investment Advisor
0.34%
Venture Capital
0.07%
Hedge Fund
0.05%
Other
94.61%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
52
134.45K
5.49%
-36.41K
2025Q1
50
565.85K
3.09%
-1.96M
2024Q4
52
608.75K
4.16%
-1.78M
2024Q3
50
1.20M
8.34%
-536.74K
2024Q2
48
484.50K
4.81%
-359.07K
2024Q1
49
447.12K
4.68%
-585.60K
2023Q4
59
755.78K
7.96%
-79.04K
2023Q3
65
452.55K
4.85%
-471.22K
2023Q2
68
440.18K
4.85%
-489.81K
2023Q1
80
515.97K
6.03%
-572.90K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Intracoastal Capital, L.L.C.
1.11M
5.22%
+1.11M
--
May 28, 2025
Geode Capital Management, L.L.C.
143.44K
0.67%
+3.93K
+2.82%
Mar 31, 2025
Tardugno (Michael H)
73.71K
0.35%
+4.57K
+6.61%
May 13, 2025
BlackRock Institutional Trust Company, N.A.
58.22K
0.27%
--
--
Mar 31, 2025
Le (Goff Corinne)
53.00K
0.25%
--
--
May 13, 2025
The Vanguard Group, Inc.
48.81K
0.23%
--
--
Mar 31, 2025
Anwer (Khursheed)
44.56K
0.21%
+31.71K
+246.67%
May 13, 2025
Lindborg (Stacy R. Ph.D.)
28.06K
0.13%
--
--
May 13, 2025
Braun (Donald P)
25.60K
0.12%
--
--
May 13, 2025
XTX Markets LLC
21.68K
0.1%
+271.00
+1.27%
Mar 31, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
날짜
유형
비율
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
Feb 28, 2022
Merger
15<1
